Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Clin Cancer Res. 2013 Dec 23;20(7):1946–1954. doi: 10.1158/1078-0432.CCR-13-1959

Table 3. Multicovariate Cox Model for Recurrence Free Survival.

Variable Hazard Ratio (95% CI) P-value
Age 1.024 (1.009, 1.039) 0.001

Stage (II vs I) 1.765 (1.239, 2.516) 0.002
   (III vs I) 2.676 (1.873, 3.824) <0.001

c-IGF-1R (per 100 increase) 1.517 (1.018, 2.259) 0.040

m-Insulin receptor (Pos vs 0) 1.442 (1.085, 1.915) 0.012

c-pAMPK (Pos vs 0) 0.648 (0.483, 0.870) 0.004

c-pmTOR (Pos vs 0) 0.696 (0.502, 0.963) 0.029

c-CXCR2 (above vs below median) 1.360 (1.017, 1.820) 0.038

c-EPCAM (Pos vs 0) 0.708 (0.524, 0.956) 0.024

m-CASK (per 100 increase) 0.680 (0.470, 0.998) 0.049

c: cytoplasmic, m: membrane